Are you Dr. Farley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-6749Fax+1 410-328-6136
Summary
- Dr. John Farley Jr., MD is a pediatric endocrinologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with University of Maryland Medical Center and is a Clinical Associate Professor at University of Maryland School of Medicine.
Education & Training
- Children's National HospitalResidency, Pediatrics, 1981 - 1985
- George Washington University School of Medicine and Health SciencesClass of 1981
Certifications & Licensure
- MD State Medical License 1985 - 2026
- American Board of Pediatrics Pediatrics
Clinical Trials
- IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 45 citationsMedication Adherence in Children and Adolescents with HIV Infection: Associations with Behavioral ImpairmentKathleen Malee, Paige L. Williams, Grace Montepiedra, Marie McCabe, Sharon Nichols
AIDS Patient Care and Stds. 2011-03-06 - 46 citationsThe role of cognitive functioning in medication adherence of children and adolescents with HIV infection.Kathleen Malee, Paige L. Williams, Grace Montepiedra, Sharon Nichols, Patricia A. Sirois
Journal of Pediatric Psychology. 2008-07-22 - 36 citationsClinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in NigeriaWalter Royal, Mariana Cherner, Jean K. Carr, Abdulrazaq Garba Habib, Abimbola Akomolafe
Journal of Neurovirology. 2012-04-18
Press Mentions
- FDA Approves New Drug To Prevent RSV in Babies and ToddlersJuly 18th, 2023
- FDA Approves First Monoclonal Injection To Prevent RSV in Infants, ToddlersJuly 25th, 2023
Grant Support
- Pharmaacokinetic Properties Of Antiretroviral Drugs During Pregnancy (Pactg P1)National Center For Research Resources2005
- Peer Education And Adherence To HIV Therapy In ChildrenEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002